{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:08:44Z","timestamp":1790359724305,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.clineuro.2021.106542","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T22:14:30Z","timestamp":1612304070000},"page":"106542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China"],"prefix":"10.1016","volume":"203","author":[{"given":"Qian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clineuro.2021.106542_bib0005","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.clineuro.2021.106542_bib0010","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.clineuro.2021.106542_bib0015","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.clineuro.2021.106542_bib0020","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4103\/0366-6999.180514","article-title":"Autoimmune encephalitis: an expanding frontier of neuroimmunology","volume":"129","author":"Guan","year":"2016","journal-title":"Chin. Med. J. (Engl)"},{"issue":"5","key":"10.1016\/j.clineuro.2021.106542_bib0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"Van Sonderen","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.clineuro.2021.106542_bib0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yebeh.2015.12.041","article-title":"Clinical characterization of autoimmune LGI1 antibody limbic encephalitis","volume":"56","author":"Gao","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.clineuro.2021.106542_bib0035","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2147\/NDT.S136723","article-title":"Clinical features of limbic encephalitis with LGI1 antibody","volume":"13","author":"Wang","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.clineuro.2021.106542_bib0040","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunptherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain."},{"issue":"June 13","key":"10.1016\/j.clineuro.2021.106542_bib0045","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2147\/NDT.S136723","article-title":"Clinical features of limbic encephalitis with LGI1 antibody","volume":"16","author":"Wang","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"December4","key":"10.1016\/j.clineuro.2021.106542_bib0050","first-page":"461","article-title":"Seizure semiology of anti-LGI1 antibody encephalitis.Beimer N.J., Selwa LM","volume":"19","year":"2017","journal-title":"Epileptic Disord."},{"issue":"5","key":"10.1016\/j.clineuro.2021.106542_bib0055","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","article-title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes","volume":"89","author":"Binks","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"August2","key":"10.1016\/j.clineuro.2021.106542_bib0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2021.106542_bib0065","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-223484","article-title":"Possible anti-VGKC autoimmune limbic encephalitis associated with SIADH","author":"Black","year":"2018","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.clineuro.2021.106542_bib0070","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol. Rev."},{"issue":"46","key":"10.1016\/j.clineuro.2021.106542_bib0075","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J. Neurosci."},{"issue":"October10","key":"10.1016\/j.clineuro.2021.106542_bib0080","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.autrev.2016.07.018","article-title":"From VGKC to LGI1 and Caspr2 encephalitis: the evolution of a disease entity over time","volume":"15","author":"van Sonderen","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.clineuro.2021.106542_bib0085","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng832","article-title":"Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features","volume":"30","author":"KALACHIKOV","year":"2002","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.clineuro.2021.106542_bib0090","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/hmg\/11.9.1119","article-title":"Mutations in the LGI1\/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy","volume":"11","author":"Morante-Redolat","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.clineuro.2021.106542_bib0095","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.autrev.2016.07.018","article-title":"From VGKC to LGI1 and Caspr2 encephalitis: the evolution of a disease entity over time","volume":"15","author":"Van Sonderen","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"76","key":"10.1016\/j.clineuro.2021.106542_bib0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.seizure.2019.12.023","article-title":"The exploration of the spectrum of motor manifestations of anti-LGI1 encephalitis beyond FBDS [published online ahead of print, 2020 Jan 2]","author":"Liu","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.clineuro.2021.106542_bib0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuroscience.2015.05.037","article-title":"Imaging of autoimmune encephalitis--Relevance for clinical practice and hippocampal function","volume":"309","author":"Heine","year":"2015","journal-title":"Neuroscience"},{"issue":"300","key":"10.1016\/j.clineuro.2021.106542_bib0110","article-title":"The expanding spectrum of clinically-distinctive, immunotherapy-responsive autoimmune encephalopathies","volume":"70","author":"Irani","year":"2012","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.clineuro.2021.106542_bib0115","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1007\/s00415-013-7048-2","article-title":"Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types","volume":"260","author":"Baumgartner","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2021.106542_bib0120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2377-14-136","article-title":"Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography","volume":"14","author":"Wegner","year":"2014","journal-title":"BMC Neurol."},{"key":"10.1016\/j.clineuro.2021.106542_bib0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12974-018-1314-2","article-title":"LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis","volume":"15","author":"Jang","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.clineuro.2021.106542_bib0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00234-017-1956-2","article-title":"Metabolic topography of autoimmune non-paraneoplastic encephalitis","volume":"60","author":"Tripathi","year":"2018","journal-title":"Neuroradiology"},{"key":"10.1016\/j.clineuro.2021.106542_bib0135","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2021.106542_bib0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","article-title":"VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy","volume":"265","author":"Shin","year":"2013","journal-title":"J. Neuroimmunol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384672100069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384672100069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:36:35Z","timestamp":1759588595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030384672100069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":28,"alternative-id":["S030384672100069X"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106542","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106542"}}